TrialJournal of Alzheimer's disease : JAD2024

Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study.

Gus Alva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.